Cargando…
Therapeutic Experience of Saxagliptin as First Add-on after Metformin in Indian Type 2 Diabetes Patients: A Non-interventional, Prospective, Observational Study (ONTARGET-INDIA)
INTRODUCTION: Dipeptidyl peptidase 4 (DPP4) inhibitors are widely used in type 2 diabetes mellitus (T2DM) patients but the data available in existing clinical trial programmes on DPP4 inhibitors include limited number of patients from India. Hence, this study attempted to understand usage, efficacy...
Autores principales: | Kalra, Sanjay, Bajaj, Sarita, Unnikrishnan, A. G., Baruah, Manash P., Sahay, Rakesh, Hardik, V., Kumar, Amit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6683677/ https://www.ncbi.nlm.nih.gov/pubmed/31641633 http://dx.doi.org/10.4103/ijem.IJEM_56_19 |
Ejemplares similares
-
Publication trends in the Indian Journal of Endocrinology and Metabolism
por: Kalra, Sanjay, et al.
Publicado: (2011) -
A revisit to prevailing care and challenges of managing diabetes in India: Focus on regional disparities
por: Baruah, Manash P., et al.
Publicado: (2014) -
Health economics in India: The case of diabetes mellitus
por: Sahay, Rakesh, et al.
Publicado: (2014) -
Person centered care in the Second Diabetes Attitudes, Wishes and Needs (DAWN2) study: Inspiration from India
por: Kalra, Sanjay, et al.
Publicado: (2014) -
Endocrine Society of India management guidelines for patients with thyroid nodules: A position statement
por: Unnikrishnan, A. G., et al.
Publicado: (2011)